August 23, 2012

Toshiba's Aquilion RXL Receives FDA Clearance

August 23, 2012—Toshiba America Medical Systems, Inc. (Tustin, CA) announced that it has received US Food and Drug Administration clearance for its Aquilion RXL edition computed tomography (CT) system.

According to the company, the Aquilion RXL incorporates advanced radiation dose-reduction technology to the 16-detector row CT system with Toshiba's Adaptive Iterative Dose Reduction 3D (AIDR 3D). Toshiba stated that AIDR 3D lowers the dose of radiation compared with conventional scanning, aiding clinicians in accurate diagnoses and treatment planning. AIDR 3D is an algorithm designed to work in both the raw data and image data spaces, reducing noise while attempting to maintain image quality.

As noted in the company's announcement, the system also features Toshiba's NEMA XR 25 dose-check software, which improves user awareness of the radiation dose administered to patients, and Toshiba's suite of SureTechnologies, which increases clinical capabilities and productivity.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

August 23, 2012

Toshiba's Aquilion RXL Receives FDA Clearance

Current Issue

Keep In Touch